WAN YONGQIN,PAN SHIFENG,ZHANG GUOBAO,WANG XIA,XIE YUN FENG,JIANG JIQING,PHILLIPS DEAN,YANG YANG
申请号：
IN7501/DELNP/2010
公开号：
IN2010DN07501A
申请日:
2010.10.25
申请国别(地区):
IN
年份:
2012
代理人:
摘要：
The invention provides a novel class of compounds, pharmaceutical compositions comprising such compounds and methods of using such compounds to treat or prevent diseases or disorders associated with abnormal or deregulated B cell activities, particularly diseases or disorders that involve aberrant activation of inositol 1,4,5-trisphosphate 3-kinase B (ITPKb).
